These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23346887)

  • 1. Ezetimibe-Simvastatin, a pharmacodynamic interaction?
    Lozano R; Marin R; Santacruz MJ; Freire I
    Expert Opin Pharmacother; 2013 Feb; 14(3):359-60. PubMed ID: 23346887
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia.
    Florentin M; Liberopoulos EN; Moutzouri E; Rizos CV; Tselepis AD; Elisaf MS
    Curr Med Res Opin; 2011 Mar; 27(3):685-92. PubMed ID: 21271793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers.
    Efrati S; Averbukh M; Dishy V; Faygenzo M; Friedensohn L; Golik A
    Eur J Clin Pharmacol; 2007 Feb; 63(2):113-21. PubMed ID: 17200833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study.
    Ballantyne CM; Abate N; Yuan Z; King TR; Palmisano J
    Am Heart J; 2005 Mar; 149(3):464-73. PubMed ID: 15864235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Pearson T; Ballantyne C; Sisk C; Shah A; Veltri E; Maccubbin D
    Am J Cardiol; 2007 Jun; 99(12):1706-1713. PubMed ID: 17560879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin.
    Kosoglou T; Meyer I; Veltri EP; Statkevich P; Yang B; Zhu Y; Mellars L; Maxwell SE; Patrick JE; Cutler DL; Batra VK; Affrime MB
    Br J Clin Pharmacol; 2002 Sep; 54(3):309-19. PubMed ID: 12236852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezetimibe and low density lipoprotein subfractions: an ongoing debate.
    Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
    Curr Med Res Opin; 2011 Mar; 27(3):693-5. PubMed ID: 21275848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia.
    Yoon HS; Kim SH; Kim JK; Ko SH; Ko JE; Park SJ; Park MG; Lee JH; Hyon MS
    Ann Pharmacother; 2011 Jul; 45(7-8):841-9. PubMed ID: 21693699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial.
    Berneis K; Rizzo M; Berthold HK; Spinas GA; Krone W; Gouni-Berthold I
    Eur Heart J; 2010 Jul; 31(13):1633-9. PubMed ID: 20525999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.
    Olijhoek JK; Hajer GR; van der Graaf Y; Dallinga-Thie GM; Visseren FL
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):145-50. PubMed ID: 18670365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
    Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
    J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
    Robinson JG; Davidson MH
    Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):461-76. PubMed ID: 16918265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease.
    Farnier M; Volpe M; Massaad R; Davies MJ; Allen C
    Int J Cardiol; 2005 Jul; 102(2):327-32. PubMed ID: 15982505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ezetimibe and simvastatin on monocyte cytokine release in patients with isolated hypercholesterolemia.
    Krysiak R; Okopien B
    J Cardiovasc Pharmacol; 2011 Apr; 57(4):505-12. PubMed ID: 21297492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypolipidemic and pleiotropic effects of a combination of simvastatin and ezetimibe in patients with different types of hyperlipidemia].
    Sumarokov AB; Kukharchuk VV
    Ter Arkh; 2014; 86(12):107-15. PubMed ID: 25804051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ezetimibe in diabetes: more than cholesterol lowering?
    Sarigianni M; Katsiki N; Mikhailidis DP
    Curr Med Res Opin; 2010 Oct; 26(10):2517-20. PubMed ID: 20843163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of simvastatin and ezetimibe on interleukin-6 and high-sensitivity C-reactive protein.
    Berthold HK; Berneis K; Mantzoros CS; Krone W; Gouni-Berthold I
    Scand Cardiovasc J Suppl; 2013 Feb; 47(1):20-7. PubMed ID: 23013513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans.
    Landmesser U; Bahlmann F; Mueller M; Spiekermann S; Kirchhoff N; Schulz S; Manes C; Fischer D; de Groot K; Fliser D; Fauler G; März W; Drexler H
    Circulation; 2005 May; 111(18):2356-63. PubMed ID: 15867181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dual inhibition of cholesterol using the drug combination ezetimibe/simvastatin?].
    Vaverková H
    Vnitr Lek; 2007 Apr; 53(4):421-7. PubMed ID: 17578178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.
    Feldman T; Koren M; Insull W; McKenney J; Schrott H; Lewin A; Shah S; Sidisin M; Cho M; Kush D; Mitchel Y
    Am J Cardiol; 2004 Jun; 93(12):1481-6. PubMed ID: 15194017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.